Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

79 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
CD34+ cell dose requirements for rapid engraftment in a sequential high-dose chemotherapy regimen of paclitaxel, melphalan, and cyclophosphamide, thiotepa, and carboplatin (CTCb) with PBPC support in metastatic breast cancer.
Papadopoulos KP, Ayello J, Reiss RF, Troxel A, Kaufman E, Vahdat LT, Antman KH, Hesdorffer CS. Papadopoulos KP, et al. Among authors: vahdat lt. J Hematother Stem Cell Res. 1999 Aug;8(4):357-63. doi: 10.1089/152581699320117. J Hematother Stem Cell Res. 1999. PMID: 10634173 Clinical Trial.
79 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page